CLINICAL_TRIALS
trial_result
· 2018-03-09
Clinical Trial Update: Tecemotide (L-BLP25) in Prostate Cancer [Phase 2]
Summary
A Phase 2 trial of Tecemotide (L-BLP25) for prostate cancer completed, with results posted in March 2018.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: EMD Serono | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2018-03-09